loading
Schlusskurs vom Vortag:
$5.82
Offen:
$5.83
24-Stunden-Volumen:
160.16K
Relative Volume:
0.59
Marktkapitalisierung:
$148.24M
Einnahmen:
$34.26M
Nettoeinkommen (Verlust:
$-46.61M
KGV:
-1.162
EPS:
-5.1806
Netto-Cashflow:
$-62.01M
1W Leistung:
+10.63%
1M Leistung:
+30.07%
6M Leistung:
+5.75%
1J Leistung:
+30.07%
1-Tages-Spanne:
Value
$5.82
$6.22
1-Wochen-Bereich:
Value
$5.3487
$6.22
52-Wochen-Spanne:
Value
$3.53
$8.82

Precision Biosciences Inc Stock (DTIL) Company Profile

Name
Firmenname
Precision Biosciences Inc
Name
Telefon
919-314-5512
Name
Adresse
302 EAST PETTIGREW STREET, DURHAM, NC
Name
Mitarbeiter
68
Name
Nächster Verdiensttermin
2026-03-12
Name
Neueste SEC-Einreichungen
Name
DTIL's Discussions on Twitter

Compare DTIL vs VRTX, REGN, ARGX, ALNY, INSM

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
DTIL icon
DTIL
Precision Biosciences Inc
5.995 143.91M 34.26M -46.61M -62.01M -5.1806
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
433.68 111.45B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
762.51 80.54B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
747.60 46.32B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
331.03 42.29B 3.71B 313.75M 465.38M 2.2571
INSM icon
INSM
Insmed Inc
163.76 35.01B 606.42M -1.28B -997.58M -6.403

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-10 Hochstufung BMO Capital Markets Market Perform → Outperform
2024-04-30 Eingeleitet Guggenheim Buy
2022-06-17 Eingeleitet BMO Capital Markets Outperform
2022-06-09 Herabstufung William Blair Outperform → Mkt Perform
2020-07-27 Fortgesetzt BTIG Research Buy
2020-04-03 Herabstufung Goldman Buy → Neutral
2020-03-05 Eingeleitet Stifel Buy
2020-02-25 Eingeleitet William Blair Outperform
2019-08-09 Eingeleitet BTIG Research Buy
2019-07-16 Eingeleitet H.C. Wainwright Buy
2019-04-22 Eingeleitet Barclays Overweight
2019-04-22 Eingeleitet Goldman Buy
2019-04-22 Eingeleitet JP Morgan Overweight
2019-04-22 Eingeleitet Jefferies Buy
Alle ansehen

Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten

pulisher
Apr 04, 2026

Precision BioSciences Inc at TD Cowen Healthcare Conference Transcript - gurufocus.com

Apr 04, 2026
pulisher
Apr 02, 2026

DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Apr 02, 2026
pulisher
Mar 31, 2026

DTIL Stock Price, Quote & Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Mar 31, 2026
pulisher
Mar 30, 2026

Quarterly Recap: What is the long term forecast for Precision BioSciences Inc stockExit Point & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 28, 2026

FOMO Trade: How does Precision BioSciences Inc perform in inflationary periodsPortfolio Return Report & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 28, 2026
pulisher
Mar 28, 2026

Aug Action: Is Precision BioSciences Inc stock trending bullishInsider Buying & Expert Curated Trade Ideas - baoquankhu1.vn

Mar 28, 2026
pulisher
Mar 27, 2026

3.8M-share increase, director elections and charter change at Precision BioSciences (NASDAQ: DTIL) - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

Will Precision BioSciences Inc be affected by tariffs2026 Biggest Moves & Growth Focused Entry Point Reports - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

VIX Spike: How does Precision BioSciences Inc compare to its peersQuarterly Risk Review & Consistent Profit Focused Trading Strategies - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 25, 2026

Decliners Report: Is Rafael Holdings Inc Equity Warrant stock a good dividend stockProduct Launch & Safe Swing Trade Setups - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 25, 2026

Precision BioSciences (DTIL) surpasses Q4 earnings and revenue estimates - MSN

Mar 25, 2026
pulisher
Mar 24, 2026

Meme Stocks: What is the PEG ratio of Precision BioSciences Inc2026 Opening Moves & Risk Managed Investment Strategies - baoquankhu1.vn

Mar 24, 2026
pulisher
Mar 24, 2026

Precision BioSciences (DTIL) Expected to Announce Earnings on Tuesday - MarketBeat

Mar 24, 2026
pulisher
Mar 23, 2026

Q1 EPS Estimate for Precision BioSciences Raised by Analyst - MarketBeat

Mar 23, 2026
pulisher
Mar 21, 2026

If You Invested $1,000 in Precision Biosciences (DTIL) - Stock Titan

Mar 21, 2026
pulisher
Mar 21, 2026

Growth Value: How does Precision BioSciences Inc compare to its peers2026 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 20, 2026

Brokers Set Expectations for DTIL Q1 Earnings - MarketBeat

Mar 20, 2026
pulisher
Mar 20, 2026

ETFs Investing in Precision BioSciences, Inc. Stocks - TradingView

Mar 20, 2026
pulisher
Mar 18, 2026

Portfolio Recap: Is Precision BioSciences Inc likely to announce a buybackTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

Precision BioSciences, Inc. (DTIL) Shareholder/Analyst CallSlideshow (NASDAQ:DTIL) 2026-03-18 - Seeking Alpha

Mar 18, 2026
pulisher
Mar 18, 2026

Jones Trading reiterates Precision BioSciences stock rating on DMD trial design - Investing.com Canada

Mar 18, 2026
pulisher
Mar 18, 2026

Jones Trading reiterates Precision BioSciences stock rating on DMD trial design By Investing.com - Investing.com South Africa

Mar 18, 2026
pulisher
Mar 17, 2026

Precision BioSciences Announces PBGENE-DMD Investor Update and Highlights ARCUS Gene Editing Platform – March 2026 - Minichart

Mar 17, 2026
pulisher
Mar 17, 2026

Precision BioSciences Highlights PBGENE-DMD Program and Trial - TipRanks

Mar 17, 2026
pulisher
Mar 17, 2026

PBGENE-DMD gene editing strategy at Precision BioSciences (NASDAQ: DTIL) - Stock Titan

Mar 17, 2026
pulisher
Mar 16, 2026

Quarterly Risk: How volatile is Precision BioSciences Inc stockEarnings Overview Report & Daily Stock Trend Watchlist - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 15, 2026

Precision BioSciences (DTIL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 15, 2026
pulisher
Mar 14, 2026

Precision BioSciences Stock (ISIN: US74019P1084) Surges on Q4 Profit Turnaround Amid Analyst Upgrade - AD HOC NEWS

Mar 14, 2026
pulisher
Mar 14, 2026

Precision BioSciences (NASDAQ:DTIL) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Mar 14, 2026
pulisher
Mar 13, 2026

Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative - simplywall.st

Mar 13, 2026
pulisher
Mar 13, 2026

Precision BioSciences Inc buy Jefferies Financial Group Inc. - sharewise.com

Mar 13, 2026
pulisher
Mar 13, 2026

Jefferies cuts Precision BioSciences stock price target on valuation By Investing.com - Investing.com Australia

Mar 13, 2026
pulisher
Mar 13, 2026

DTIL SEC FilingsPrecision Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 13, 2026
pulisher
Mar 13, 2026

Jefferies cuts Precision BioSciences stock price target on valuation - Investing.com

Mar 13, 2026
pulisher
Mar 13, 2026

Precision BioSciences Advances PBGENE-DMD Trial, Putting New Focus on Duchenne Gene Therapy - TipRanks

Mar 13, 2026
pulisher
Mar 13, 2026

Jefferies Maintains Buy for Precision BioSciences (DTIL) March 13, 2026 - Meyka

Mar 13, 2026
pulisher
Mar 13, 2026

Precision BioSciences (NASDAQ:DTIL) Trading Up 12.1%Here's Why - MarketBeat

Mar 13, 2026
pulisher
Mar 12, 2026

Precision BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences (DTIL) Swings to $1.05 EPS in Q4, Reversing $2.22 Year-Ago Loss - AlphaStreet

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences (DTIL) Exceeds Expectations for Q4 Earnings and Revenue - Bitget

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Bus - PharmiWeb.com

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences presents preclinical data on DMD therapy By Investing.com - Investing.com Nigeria

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update - BioSpace

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences (DTIL) Surpasses Q4 Revenue Expectations - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences (DTIL) Surges After Strong Q4 Earnings Bea - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences Q4 2025 Earnings: $20.1M Profit on $34.2M RevenueNews and Statistics - IndexBox

Mar 12, 2026
pulisher
Mar 12, 2026

Precision Biosciences 2025 10-K: Revenue $34.3M, GAAP net loss $(45.7M) - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences (NASDAQ: DTIL) turns Q4 profit and extends cash runway to 2028 - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Precision BioSciences: Q4 Earnings Snapshot - Barchart.com

Mar 12, 2026

Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Precision Biosciences Inc-Aktie (DTIL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Amoroso Michael
President and CEO
Feb 18 '26
Sale
3.84
20,559
78,947
243,392
Kelly John Alexander
Chief Financial Officer
Feb 17 '26
Option Exercise
0.00
27,584
0
134,032
Kelly John Alexander
Chief Financial Officer
Feb 18 '26
Sale
3.84
8,149
31,292
125,883
Scimeca Dario
General Counsel and Secretary
Feb 17 '26
Option Exercise
0.00
16,667
0
61,382
Scimeca Dario
General Counsel and Secretary
Feb 18 '26
Sale
3.84
4,925
18,912
56,457
SMITH J. JEFFERSON
Chief Research Officer
Feb 17 '26
Option Exercise
0.00
16,667
0
126,851
SMITH J. JEFFERSON
Chief Research Officer
Feb 18 '26
Sale
3.84
4,925
18,912
121,926
$49.55
price down icon 1.90%
$28.34
price up icon 1.08%
$47.79
price down icon 1.05%
$91.15
price up icon 0.08%
ONC ONC
$311.43
price up icon 0.93%
$163.18
price down icon 1.52%
Kapitalisierung:     |  Volumen (24h):